Abstract
The WHO Consensus Documents Series on Clinical Investigation covers many different therapeutic drug groups including the antibacterial drugs. The documents have been produced by the WHO Regional Office for Europe in collaboration with a wide group of clinicians and other experts in order to define and promote agreement on current and emerging standards for the clinical investigation of drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Declaration of Helsinki. Recommendations guiding medical doctors on biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964, and revised by the 29th World Medical Assembly, Tokyo, Japan, 1975.
Norrby R: Quality of antibiotic trials. Journal of Antimicrobial Chemotherapy 1984, 14: 205–208.
Nordic Council on Medicine: Clinical trials of drugs. Nordic guidelines. NLN Publication no. 11. Nordiska Läkemedelsnämnden, Uppsala, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lunde, I. Guidelines of the world health organization for clinical trials with antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 9, 548–551 (1990). https://doi.org/10.1007/BF01964301
Issue Date:
DOI: https://doi.org/10.1007/BF01964301